Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 31 AL 45

Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective

Rajah Kumaran K, Yunusa S, Perimal E, Wahab H, Müller CP, Hassan Z.

J Alzheimers Dis. 2023;91(2):507-530. doi: 10.3233/JAD-220666.

Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial

Noguchi-Shinohara M, Hamaguchi T, Sakai K, Komatsu J, Iwasa K, Horimoto M, Nakamura H, Yamada M, Ono K.

J Alzheimers Dis. 2023;91(2):805-814. doi: 10.3233/JAD-220953.

Mutual Prodrugs - Codrugs

Nudelman A.

Curr Med Chem. 2023;30(38):4283-4339. doi: 10.2174/0929867330666221209102650.

A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease

Patel A, Shah D, Patel Y, Patel S, Mehta M, Bambharoliya T.

Curr Drug Targets. 2023;24(3):225-246. doi: 10.2174/1389450124666221213114500.

Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs

Alan E, Kerry Z, Sevin G.

Fundam Clin Pharmacol. 2023 Jun;37(3):397-427. doi: 10.1111/fcp.12861. Epub 2023 Jan 13.

Drug Discovery to Drug Development of BACE1 Inhibitor as Antialzheimer's: A Review

Munj SM, Patil PB.

Curr Top Med Chem. 2023;23(2):77-97. doi: 10.2174/1568026623666221228140450.

Role of primary aging hallmarks in Alzheimer´s disease

Zhao J, Huai J.

Theranostics. 2023 Jan 1;13(1):197-230. doi: 10.7150/thno.79535. eCollection 2023.

Pharmacogenetics of anxiety and depression in Alzheimer's disease

Cacabelos R, Carril JC, Corzo L, Pego R, Cacabelos N, Alcaraz M, Muñiz A, Martínez-Iglesias O, Naidoo V.

Pharmacogenomics. 2023 Jan;24(1):27-57. doi: 10.2217/pgs-2022-0137. Epub 2023 Jan 11.

Impact of nanoparticles on amyloid β-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review

Chakraborty A, Mohapatra SS, Barik S, Roy I, Gupta B, Biswas A.

Biosci Rep. 2023 Feb 27;43(2):BSR20220324. doi: 10.1042/BSR20220324.

The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease

Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M.

Biomed Pharmacother. 2023 Mar;159:114223. doi: 10.1016/j.biopha.2023.114223. Epub 2023 Jan 9.

Photobiomodulation for Alzheimer's disease: photoelectric coupling effect on attenuating Aβ neurotoxicity

Tian Z, Wang P, Huang K, Yu J, Zhang M, Liu Y, Zhao H, Zhu B, Huang X, Tong Z.

Lasers Med Sci. 2023 Jan 12;38(1):39. doi: 10.1007/s10103-022-03692-z.

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Moore KBE, Hung TJ, Fortin JS.

Drug Discov Today. 2023 Mar;28(3):103487. doi: 10.1016/j.drudis.2023.103487. Epub 2023 Jan 9.

TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment

Ayyubova G.

Eur J Neurosci. 2023 Feb;57(4):718-733. doi: 10.1111/ejn.15914. Epub 2023 Jan 29.

Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V, Askari VR.

Biofactors. 2023 May-Jun;49(3):560-583. doi: 10.1002/biof.1936. Epub 2023 Jan 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias